Specifically, 7ACC2 inhibits lactic acid influx in cancer cells expressing MCT1 and MCT4 but does not affect efflux, suggesting its mode of action differs from that of AR-C155858 (Draoui et al., 2014). The gene discussed is SLC16A1; the disease is cancer.